drugset / Trial / NCT01357356
Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the efficacy and safety of SER120 nasal spray formulations in patients with nocturia for a total duration of 14 weeks.
Timeline
- Start
- 2011-05
- Primary completion
- 2012-10
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | 750 ng | Intranasal |
| Subject | Desmopressin | Peptide | 1000 ng | Intranasal |
| Subject | Desmopressin | Peptide | 1500 ng | Intranasal |